Michael Walden

2.9k total citations
30 papers, 2.3k citations indexed

About

Michael Walden is a scholar working on Molecular Biology, Spectroscopy and Nephrology. According to data from OpenAlex, Michael Walden has authored 30 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Spectroscopy and 5 papers in Nephrology. Recurrent topics in Michael Walden's work include Advanced Proteomics Techniques and Applications (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Skin and Cellular Biology Research (4 papers). Michael Walden is often cited by papers focused on Advanced Proteomics Techniques and Applications (7 papers), Mass Spectrometry Techniques and Applications (5 papers) and Skin and Cellular Biology Research (4 papers). Michael Walden collaborates with scholars based in Germany, United States and United Kingdom. Michael Walden's co-authors include Harald Mischak, Stefan Wittke, Mark M. Ross, Dan Theodorescu, Wolf‐Georg Forssmann, Ingo Just, Hermann Haller, Thorsten Kaiser, Mark R. Conaway and Henry F. Frierson and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Journal of Applied Physics.

In The Last Decade

Michael Walden

30 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Walden Germany 20 984 938 402 226 195 30 2.3k
Stefan Wittke Germany 21 1.4k 1.4× 1.1k 1.2× 480 1.2× 428 1.9× 211 1.1× 34 2.6k
Eric Schiffer Germany 25 1.0k 1.0× 885 0.9× 363 0.9× 290 1.3× 367 1.9× 59 2.3k
Justyna Siwy Germany 27 667 0.7× 859 0.9× 611 1.5× 193 0.9× 290 1.5× 94 2.4k
María G. Barderas Spain 30 450 0.5× 1.1k 1.2× 270 0.7× 82 0.4× 238 1.2× 123 2.5k
Agnieszka Latosińska Germany 23 385 0.4× 635 0.7× 190 0.5× 132 0.6× 210 1.1× 80 1.4k
Harald Tammen Germany 17 751 0.8× 825 0.9× 49 0.1× 101 0.4× 98 0.5× 37 1.5k
Denis Sviridov United States 21 236 0.2× 601 0.6× 105 0.3× 73 0.3× 392 2.0× 40 1.4k
J.G. Heathcote Canada 20 148 0.2× 454 0.5× 147 0.4× 59 0.3× 255 1.3× 107 1.9k
Natascia Campostrini Italy 31 371 0.4× 718 0.8× 49 0.1× 60 0.3× 45 0.2× 62 2.8k
Tara K. Sigdel United States 33 170 0.2× 727 0.8× 593 1.5× 71 0.3× 1.2k 6.4× 107 3.3k

Countries citing papers authored by Michael Walden

Since Specialization
Citations

This map shows the geographic impact of Michael Walden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Walden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Walden more than expected).

Fields of papers citing papers by Michael Walden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Walden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Walden. The network helps show where Michael Walden may publish in the future.

Co-authorship network of co-authors of Michael Walden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Walden. A scholar is included among the top collaborators of Michael Walden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Walden. Michael Walden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guzmán, David Sánchez-Migallón, Thomas N. Tully, Michael Walden, et al.. (2010). Evaluating 21-day Doxycycline and Azithromycin Treatments for Experimental Chlamydophila psittaci Infection in Cockatiels (Nymphicus hollandicus). Journal of Avian Medicine and Surgery. 24(1). 35–45. 27 indexed citations
2.
Mitchell, Mark A., et al.. (2009). Evaluating the Effect of Leuprolide Acetate on Testosterone Levels in Captive Male Green Iguanas (Iguana iguana). Journal of Herpetological Medicine and Surgery. 19(4). 128–128. 9 indexed citations
3.
Guzman, David Sánchez-Migallón, Mark Mitchell, Cheryl S. Hedlund, Michael Walden, & Thomas N. Tully. (2007). Tracheal Resection and Anastomosis in a Mallard Duck (Anas platyrhynchos) with Traumatic Segmental Tracheal Collapse. Journal of Avian Medicine and Surgery. 21(2). 150–157. 12 indexed citations
4.
Decramer, Stéphane, Stefan Wittke, Harald Mischak, et al.. (2006). Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nature Medicine. 12(4). 398–400. 190 indexed citations
5.
Theodorescu, Dan, Stefan Wittke, Mark M. Ross, et al.. (2006). Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. The Lancet Oncology. 7(3). 230–240. 342 indexed citations
6.
Zürbig, Petra, Matthew B. Renfrow, Eric Schiffer, et al.. (2006). Biomarker discovery by CE‐MS enables sequence analysis via MS/MS with platform‐independent separation. Electrophoresis. 27(11). 2111–2125. 163 indexed citations
7.
Weissinger, Eva M., Thao Nguyen‐Khoa, Christine Fumeron, et al.. (2005). Effects of oral vitamin C supplementation in hemodialysis patients: A proteomic assessment. PROTEOMICS. 6(3). 993–1000. 42 indexed citations
8.
Haubitz, Marion, Stefan Wittke, Eva M. Weissinger, et al.. (2005). Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney International. 67(6). 2313–2320. 186 indexed citations
9.
John, Harald, et al.. (2005). In vitro degradation of the antimicrobial human peptide HEM-γ 130–146 in plasma analyzed by a validated quantitative LC–MS/MS procedure. Analytical Biochemistry. 341(1). 173–186. 13 indexed citations
10.
Egelrud, T, Maria Brattsand, Peter Kreutzmann, et al.. (2005). hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. British Journal of Dermatology. 153(6). 1200–1203. 93 indexed citations
11.
Wittke, Stefan, Marion Haubitz, Michael Walden, et al.. (2005). Detection of Acute Tubulointerstitial Rejection by Proteomic Analysis of Urinary Samples in Renal Transplant Recipients. American Journal of Transplantation. 5(10). 2479–2488. 114 indexed citations
12.
Chalmers, Michael J., C. Logan Mackay, Christopher L. Hendrickson, et al.. (2005). Combined Top-Down and Bottom-Up Mass Spectrometric Approach to Characterization of Biomarkers for Renal Disease. Analytical Chemistry. 77(22). 7163–7171. 72 indexed citations
13.
Rossing, Kasper, et al.. (2005). Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney International. 68(1). 193–205. 116 indexed citations
14.
Theodorescu, Dan, Danilo Fliser, Stefan Wittke, et al.. (2005). Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis. 26(14). 2797–2808. 129 indexed citations
15.
Busmann, Annette, et al.. (2004). A three-step purification strategy for isolation of hamster TIG2 from CHO cells: characterization of two processed endogenous forms. Journal of Chromatography B. 811(2). 217–223. 7 indexed citations
16.
Forssmann, Ulf, Barbara Fuchs, Sylvia E. Escher, et al.. (2004). n-Nonanoyl-CC Chemokine Ligand 14, a Potent CC Chemokine Ligand 14 Analogue That Prevents the Recruitment of Eosinophils in Allergic Airway Inflammation. The Journal of Immunology. 173(5). 3456–3466. 29 indexed citations
17.
Weissinger, E. M., Thorsten Kaiser, Natalie Meert, et al.. (2004). Proteomics: a novel tool to unravel the patho-physiology of uraemia. Nephrology Dialysis Transplantation. 19(12). 3068–3077. 89 indexed citations
18.
Walden, Michael, et al.. (2002). Biochemical Features, Molecular Biology and Clinical Relevance of the Human 15-Domain Serine Proteinase Inhibitor LEKTI. Biological Chemistry. 383(7-8). 1139–1141. 16 indexed citations
19.
Uhrigshardt, Helge, Michael Walden, Harald John, Arnd Petersen, & Stefan Anemüller. (2002). Evidence for an operative glyoxylate cycle in the thermoacidophilic crenarchaeon Sulfolobus acidocaldarius. FEBS Letters. 513(2-3). 223–229. 21 indexed citations
20.
Mägert, Hans‐Jürgen, et al.. (2002). LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance. The International Journal of Biochemistry & Cell Biology. 34(6). 573–576. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026